Ganglion Cell Thickness in Enuresis Nocturna
Is Ganglion Cell Thickness the Main Problem in Enuresis Nocturna?
1 other identifier
observational
50
1 country
1
Brief Summary
The precise role of the intrinsic circadian regulatory mechanism behind the pathogenesis of enuresis is not fully understood, but in theory, circadian rhythm irregularity may be the primary pathogenic mechanism not only for urinary outflow mechanisms but also for nocturnal bladder function. The proximity between SCN centers that control AVP release, sleep/arousal, voiding, and baroreregulation may provide the basis for circadian rhythm disturbance in one or more of these biological functions. Ganglion cells containing melanopsin pigment in the retina transmit the information they receive from the outside world about the light-dark state to the SCN via the retinohypothalamic pathway. Peripapillary retinal nerve fiber layer (RNFL) thickness, optic nerve head and macula are examined most frequently for the diagnosis of glaucoma and the detection of progression with optical coherence tomography (OCT). If differences in ganglion cell thickness can be detected using OCT in these children, a new avenue in Enuresis Nocturna may be opened.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2021
CompletedFirst Posted
Study publicly available on registry
November 19, 2021
CompletedStudy Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedNovember 19, 2021
November 1, 2021
3 months
October 28, 2021
November 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in ganglion cell thickness in enuretic children
Normal values in RNFL measurements on OCT 75 (lowest)-107.2 (highest)
Baseline
Eligibility Criteria
Pediatric patients aged 5-18 years, with enuresis, without any eye disease
You may qualify if:
- be between the ages of 5-18
- have enuresis
You may not qualify if:
- have any eye conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bakircay University
Izmir, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asistant Professor
Study Record Dates
First Submitted
October 28, 2021
First Posted
November 19, 2021
Study Start
January 1, 2022
Primary Completion
April 1, 2022
Study Completion
July 1, 2022
Last Updated
November 19, 2021
Record last verified: 2021-11